SIRT1 regulates hepatic vldlr levels
Cell Communication and Signaling · 2024
DOI: 10.1186/s12964-024-01666-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Communication and Signaling, 2024. Verfasst von Mona Peyman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Barcelona, Spain. Hauptthemen laut MEDLINE: Sirtuin 1, Liver, Receptors, LDL. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Background
Endoplasmic reticulum (ER) stress-mediated increases in the hepatic levels of the very low-density lipoprotein (VLDL) receptor (VLDLR) promote hepatic steatosis by increasing the delivery of triglyceride-rich lipoproteins to the liver. Here, we examined whether the NAD( + )-dependent deacetylase sirtuin 1 (SIRT1) regulates hepatic lipid accumulation by modulating VLDLR levels and the subsequent uptake of triglyceride-rich lipoproteins.
Methods
Rats fed with fructose in drinking water, Sirt1 −/− mice, mice treated with the ER stressor tunicamycin with or without a SIRT1 activator, and human Huh-7 hepatoma cells transfected with siRNA or exposed to tunicamycin or different inhibitors were used.
Results
Hepatic SIRT1 protein levels were reduced, while those of VLDLR were upregulated in the rat model of metabolic dysfunction-associated steatotic liver disease (MASLD) induced by fructose-drinking water. Moreover, Sirt1 −/− mice displayed increased hepatic VLDLR levels that were not associated with ER stress, but were accompanied by an increased expression of hypoxia-inducible factor 1α (HIF-1α)-target genes. The pharmacological inhibition or gene knockdown of SIRT1 upregulated VLDLR protein levels in the human Huh-7 hepatoma cell line, with this increase abolished by the pharmacological inhibition of HIF-1α. Finally, SIRT1 activation prevented the increase in hepatic VLDLR protein levels in mice treated with the ER stressor tunicamycin.
Conclusions
Overall, these findings suggest that SIRT1 attenuates fatty liver development by modulating hepatic VLDLR levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Barcelona, Spain.
- Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, 08028, Spain.
- Spanish Biomedical Research Center in Diabetes and Associated Metabolic Diseases (CIBERDEM)-Instituto de Salud Carlos III, Madrid, 28029, Spain.
- Pediatric Research Institute-Hospital Sant Joan de Déu Esplugues de Llobregat, Barcelona, 08950, Spain.
- Basic Sciences Department, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, Barcelona, 08017, Spain.
- Spanish Biomedical Research Center in Physiopathology of Obesity and Nutrition (CIBEROBN)-Instituto de Salud Carlos III, Madrid, 28029, Spain.
Förderung
- Ministerio de Ciencia e Innovación
Zitieren
APA
Peyman, M., Babin-Ebell, A., Rodríguez-Rodríguez, R., Rigon, M., Aguilar-Recarte, D., Villarroya, J., Planavila, A., Villarroya, F., Palomer, X., Barroso, E., & Vázquez-Carrera, M. (2024). SIRT1 regulates hepatic vldlr levels. Cell Communication and Signaling. https://doi.org/10.1186/s12964-024-01666-y
Vancouver
Peyman M, Babin-Ebell A, Rodríguez-Rodríguez R, Rigon M, Aguilar-Recarte D, Villarroya J, et al. SIRT1 regulates hepatic vldlr levels. Cell Communication and Signaling. 2024. doi:10.1186/s12964-024-01666-y
BibTeX
@article{Peyman2024,
author = {Peyman, Mona and Babin-Ebell, Anna and Rodríguez-Rodríguez, Rosalía and Rigon, Matilde and Aguilar-Recarte, David and Villarroya, Joan and Planavila, Anna and Villarroya, Francesc and Palomer, Xavier and Barroso, Emma and Vázquez-Carrera, Manuel},
title = {SIRT1 regulates hepatic vldlr levels},
journal = {Cell Communication and Signaling},
year = {2024},
doi = {10.1186/s12964-024-01666-y}
}
EUVIMED